Bank Bumi Arta Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Bumi Arta Tbk trades at Rp745 (market cap 2.55T, 30.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bank Bumi Arta Tbk is far larger — about 15.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 30.9K). Which is the better fit depends on your goals.
| BNBA | OBAT | |
|---|---|---|
Market Cap | 2.55T | 167.37B |
Volume | 30.9K | 71K |
Lot | 309 | 710 |
Turnover | 23.06M | 17.51M |
Average Price | 746.13 | 246.63 |
Value | 23.06M | 17.51M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Bumi Arta (the company) was established under its original name of PT Bank Bumi Arta Indonesia on Mar 3, 1967 then changed to PT Bank Bumi Arta based on Notaries Deed dated Jul 19, 1989 and the deed of establishment was approved by the the Ministry of Justice dated Sept 14, 1992. The Company was merged with PT Bank Duta Nusantara (d/h PT Bank Pegawai) to improve operational banking network and to increase capital structure.The Company’s articles of association has been amended several times, most recently by notarial deed No. 8 of Fathiah Helmi, S.H., dated Mar 9, 2006, concerning company public offering.
Read more on BNBA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →